The use of the Lysate of mycobacterial (LM) and purified protein (PPD) to the diagnosis of patients with mendelian susceptibility to mycobacterial disease (MSMD) (2017)
- Authors:
- USP affiliated authors: KUBO, CHRISTINA ARSLANIAN - ICB ; CONDINO NETO, ANTONIO - ICB ; ZURRO, NURIA BENGALA - ICB
- Unidade: ICB
- DOI: 10.1007/s10875-017-0442-2
- Subjects: IMUNOLOGIA; INFECÇÕES BACTERIANAS; MACRÓFAGOS; LINFÓCITOS
- Language: Inglês
- Imprenta:
- Publisher: Springer New York LLC
- Publisher place: New York
- Date published: 2017
- Source:
- Título do periódico: Journal of Clinical Immunology
- ISSN: 1573-2592
- Volume/Número/Paginação/Ano: v. 37, Supl. 1, p. S31, res. PO-084, 2017
- Conference titles: 2017 LASID Meeting Abstracts
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
ZURRO, Nuria Bengala e KUBO, Christina Arslanian e CONDINO-NETO, Antonio. The use of the Lysate of mycobacterial (LM) and purified protein (PPD) to the diagnosis of patients with mendelian susceptibility to mycobacterial disease (MSMD). Journal of Clinical Immunology. New York: Springer New York LLC. Disponível em: https://doi.org/10.1007/s10875-017-0442-2. Acesso em: 25 jul. 2024. , 2017 -
APA
Zurro, N. B., Kubo, C. A., & Condino-Neto, A. (2017). The use of the Lysate of mycobacterial (LM) and purified protein (PPD) to the diagnosis of patients with mendelian susceptibility to mycobacterial disease (MSMD). Journal of Clinical Immunology. New York: Springer New York LLC. doi:10.1007/s10875-017-0442-2 -
NLM
Zurro NB, Kubo CA, Condino-Neto A. The use of the Lysate of mycobacterial (LM) and purified protein (PPD) to the diagnosis of patients with mendelian susceptibility to mycobacterial disease (MSMD) [Internet]. Journal of Clinical Immunology. 2017 ; 37 S31.[citado 2024 jul. 25 ] Available from: https://doi.org/10.1007/s10875-017-0442-2 -
Vancouver
Zurro NB, Kubo CA, Condino-Neto A. The use of the Lysate of mycobacterial (LM) and purified protein (PPD) to the diagnosis of patients with mendelian susceptibility to mycobacterial disease (MSMD) [Internet]. Journal of Clinical Immunology. 2017 ; 37 S31.[citado 2024 jul. 25 ] Available from: https://doi.org/10.1007/s10875-017-0442-2 - BAY 41-2272, a soluble guanylate cyclase agonist, activates human mononuclear phagocytes
- A novel mutation in the NCF2 gene in a CGD patient with chronic recurrent pneumopathy
- Chronic granulomatous disease in a brazilian patient mimetizing sarcoidosis
- Peripheral blood mononuclear cells from severe asthmatic children release lower amounts of IL-12 and IL-4 after LPS stimulation
- BAY 41-2272 activates host defence against local and disseminated Candida albicans infections
- Leukocytes from wheezing infants release lower amounts of IL-12 and IFN-γ compared to non-wheezing infants
- A C126R de novo mutation in CYBB Leads to X-linked chronic granulomatous disease with recurrent pneumonia and BCGitis
- A novel mutation in CYBB gene in a patient with chronic colitis and recurrent pneumonia due to X‐linked chronic granulomatous disease
- Caracterização clínica e genética de pacientes brasileiros com doença granulomatosa crônica e susceptibilidade mendeliana a infecções por micobactérias
- Espectro clínico e defeitos genético-moleculares de pacientes com doença granulomatosa crônica
Informações sobre o DOI: 10.1007/s10875-017-0442-2 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
